Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05787379 · ClinicalTrials.gov registry record · NA
Care for Veterans Post-COVID-19
A NA study of Post-Acute COVID-19 Syndrome, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 348
- Enrollment target
- 1
- Study location
NCT05787379: Recruiting NA study of Post-Acute COVID-19 Syndrome, sponsored by VA Office of Research and Development.
NCT05787379 is a NA study of Post-Acute COVID-19 Syndrome that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 348 participants, below the 819-participant average among 14 other Post-Acute COVID-19 Syndrome trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05787379, a NA study of Post-Acute COVID-19 Syndrome, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 348 participants
- Enrollment target
- 1
- Study location
Study Summary
The evidence-based Concordant Care approach involves engaging in processes that: 1) validate the patient's experience, 2) develop a shared understanding of the condition, and 3) create a patient-centered, whole health-oriented action plan to manage the condition. This is consistent with published expert opinion that Concordant Care underlies patients' (and clinicians') positive experiences of care for poorly understood conditions. Despite strong evidence supporting this care approach, there are no interventions to train clinicians on practices to provide Concordant Care for Veterans with poorly understood conditions such as Long-COVID. Part 1 of the study will optimize and test if a Concordant Care training improves VA clinicians' engagement in recommended practices to provide Concordant Care (i.e., validate, shared understanding, action plan) for Veterans with Long-COVID. This study will adapt and refine Concordant Care training for Long-COVID. Part 2 of this study will determine if Concordant Care training increases clinicians' engagement in recommended practices to provide Concordant Care and will explore the effectiveness of Concordant Care on care outcomes including satisfaction, adherence to care, \& disability for Veterans with Long-COVID. Veterans treated by clinicians receiving Concordant Care training will report their clinician more frequently engaged in recommended conversations (i.e., ask about Long-COVID, validate experience with Long-COVID, create a shared understanding and action plan), and Veterans will perceive greater shared understanding of Long-COVID with their clinicians than Veterans treated by clinicians in the control arm.
Primary Outcome
Concordant Care practices will be measured with the 11-item measure that asks the patient if the clinician talked with them about multiple dimensions of their understanding of the health condition (i.e., cause, consequence, treatment). Participants answer yes or no to each question. Scores range from 0 to 11 with a higher score = more Concordant Care practices.
Conditions Studied
Interventions
- BEHAVIORAL Concordant Care Training
- BEHAVIORAL Education Packet Training
Study Locations (1)
New Jersey
- East Orange Campus of the VA New Jersey Health Care System, East Orange, NJ - East Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 348 participants |
| Start Date | 2025-01-01 |
| Est. Completion | 2027-11-30 |
| Phase | NA |
What NCT05787379 shows while recruiting
NCT05787379 is an interventional study that assigns participants to a tested intervention. The registered 348 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 14 other Post-Acute COVID-19 Syndrome trials with a reported enrollment target (58% lower).
The record links to 1 condition, with Post-Acute COVID-19 Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Concordant Care Training is the first listed.
NCT05787379 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT05787379 about?
NCT05787379 is a clinical study titled "Care for Veterans Post-COVID-19". The evidence-based Concordant Care approach involves engaging in processes that: 1) validate the patient's experience, 2) develop a shared understanding of the condition, and 3) create a patient-centered, whole health-oriented action plan to manage the condition. This is consistent with published ex...
What is the current status of trial NCT05787379?
This trial is currently recruiting. It is a NA study. The enrollment target is 348 participants. The study started on 2025-01-01. Estimated completion is 2027-11-30.
What conditions does trial NCT05787379 study?
This clinical trial studies the following conditions: Post-Acute COVID-19 Syndrome.
What interventions are being tested in trial NCT05787379?
The interventions under investigation include: Concordant Care Training (BEHAVIORAL), Education Packet Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT05787379?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05787379 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post-Acute COVID-19 Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05787379's enrollment target sits among peer trials
348 4th of 14 higher than 11 of 14 other Post-Acute COVID-19 Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post-Acute COVID-19 Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Brain-Training Treatment for Long COVID in Older Adults
RECRUITING · NA
-
Long-Covid-19 Alleviation Through Learning Mindfulness Study
RECRUITING · NA
-
Long COVID Brain Fog: Cognitive Rehabilitation Trial
RECRUITING · NA
-
Dietary Intervention to Mitigate Post-Acute COVID-19 Syndrome
RECRUITING · NA
-
Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome
RECRUITING · NA
-
A Study of Positive Emotions With Long COVID-19
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04041479 · 348 participants · Phase 3
Biomarker-guided rTMS for Treatment Resistant Depression
- NCT04530565 · 348 participants · Phase 3
Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults
- NCT05428735 · 348 participants · NA
The DRAGON 2 Trial
- NCT05815784 · 348 participants · Phase 2
Myopia Control: a Comparison Study Between Atropine and MiSight
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI